CSIMarket
 


Henry Schein Inc   (NASDAQ: HSIC)
Other Ticker:  
 

 


Henry Schein Inc 's ROA from the first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Henry Schein Inc 's ROA in the first quarter of 2025?
Henry Schein Inc achieved a return on average assets (ROA) of 4.09 % in its first quarter of 2025, which is below Henry Schein Inc 's average return on assets, which stands at 7.13%.

ROA has improved compared to 3.98% in the fourth quarter of 2024, due to net income growth.

However, within the Healthcare sector 118 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 29 2025 quarter, so far to 1073, from total ROA ranking in the fourth quarter of 2024 at 1364.

What is ROA?


Return On Assets (Mar 29 2025)
I. Quarter
(Dec 28 2024)
IV. Quarter
(Sep 28 2024)
III. Quarter
(Jun 29 2024)
II. Quarter
(Mar 30 2024)
I. Quarter
Y / Y Total Assets Change 3.61 % -3.15 % 8.58 % 12.32 % 18.56 %
Y / Y Net Income Change 15.31 % 464.71 % -30.77 % -29.05 % -23.44 %
Net Income (TTM) in million 413 398 319 363 406
Return On Assets (TTM) 4.09 % 3.98 % 3.16 % 3.67 % 4.23 %
HSIC's Total Ranking # 1073 # 1364 # 1462 # 1410 # 1309
Total Assets (TTM) in million 10,186 9,925 10,301 9,947 9,831
Seq. Total Assets Change 2.63 % -3.65 % 3.56 % 1.18 % -4.07 %
Seq. Net Income Change 17.71 % -3.03 % -5.71 % 7.14 % 476.47 %



Return On Assets Company Ranking
Within: No.
Industry # 31
Sector # 119
Overall # 1071

Return On Assets Statistics
High Average Low
10.23 %
7.13 %
3.07 %
(Mar 28 2020)   (Sep 28 2024)



  News about Henry Schein Inc

Henry Schein Activates Customer Assistance Hotline Ahead of Hurricane Milton A Lifeline for Healthcare Professionals

As Hurricane Milton approaches the southeastern coast of the United States, Henry Schein, Inc. (Nasdaq: HSIC), a prominent provider of healthcare products and services, has taken proactive measures to support its customers in Florida and surrounding areas. The company has announced the opening of a dedicated Customer Assistance Hotline, available 24/7, to assist dental and medical professionals who may face operational, logistical, or financial challenges due to the impending storm. Key Facts:1. Hotline Activation : The hotline, which can be reached at 800-999-9729, is designed to provide real-time support and assistance for healthcare providers impacted by Hurricane Milton.

Henry Schein Balances Relief Efforts and Financial Challenges Amidst Hurricane Crisis,

Henry Schein Pledges Support for Hurricane Relief Amidst Financial Challenges Company Aids Southeast US with Significant Donations MELVILLE, N.Y. In a humanitarian move marked by significant financial contributions, Henry Schein, Inc. (Nasdaq: HSIC), a prominent provider of health care products and services, has announced the launch of the Henry Schein Cares Foundation 2024 Relief Fund. This initiative is poised to provide substantial aid to communities in the Southeast United States severely impacted by Hurricane Helene.In this robust display of corporate social responsibility, both Henry Schein, Inc. and the Henry Schein Cares Foundation have committed to an initial donation of $25,000 each to kick-start the relief efforts. Additional support will be garnered through a dollar-for-dollar matching of Team Schein Member (TSM) contributions up to $50,000, bringing the total potential cash donation to $150,000. Moreover, the company is pledging up to $500,000 in cash and essential healthcare supplies to further bolster the relief mission.

Henry Schein?s Triple Impact Navigating Disaster, Promoting Diversity, and Empowering Students Globally,

Henry Schein s Multi-Faceted Commitment: From Hurricane Preparedness to Educational Empowerment By , Special Correspondent for CSIMarket.com In a rapidly changing world where the intersection of healthcare, education, and community support is more critical than ever, few companies have demonstrated comprehensive responsiveness as effectively as Henry Schein, Inc. (Nasdaq: HSIC). The multinational healthcare products distributor has unveiled several initiatives aimed at aiding communities, spanning from disaster response and promoting diversity in dentistry to bolstering educational support for underprivileged students. Here?s a closer look at three key initiatives and their overall impact on the company?s reputation and operational strategy. Hurricane Helene: Proactive Disaster ResponseWith Hurricane Helene threatening to inflict severe damage along its projected path, Henry Schein has promptly activated its Customer Assistance Hotline to support healthcare providers like dentists and physicians who might experience operational, logistical, or financial disruptions. By dialing 800-999-9729, affected customers can receive real-time assistance around the clock from Team Schein. This proactive disaster response showcases the company?s commitment to maintaining the healthcare landscape s resilience, even under dire circumstances.

Henry Schein Inc Building a Healthy Future Amidst Market Volatility

As the global markets continue to grapple with uncertainty and volatility, healthcare solutions provider Henry Schein Inc has been navigating the challenges with resilience and determination. While facing moderate setbacks, this innovative company has shown promising growth prospects, further enhancing its position as a frontrunner within the healthcare sector. This article delves into the recent developments surrounding Henry Schein Inc and sheds light on its performance amidst volatile market conditions.Henry Schein s Strong Performance Amidst Market Turbulence:In recent reports by leading financial analyst firms, Henry Schein Inc has consistently showcased its ability to outperform competitors even during challenging trading days. Supported by world-class markets data from CSIMarket.com and FactSet, the company s trading performance has demonstrated stability and resilience. This achievement is further strengthened by its valuable partnership with Automated Insights, which enables the delivery of timely and relevant content to stakeholders.




Financial Statements
Henry Schein Inc 's Assets $ 10,186 million HSIC's Balance sheet
Henry Schein Inc 's Income $ 113 million Quarterly HSIC's Income Statement
HSIC's Income by Division See HSIC's Income by Division



Annual Return On Assets (Dec 28 2024)
FY 2024
(Dec 30 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 25 2021)
FY 2021
(Dec 26 2020)
FY 2020
Y / Y Total Assets Change -3.15 % 23.13 % 2.05 % 8.99 % 8.15 %
Total Assets in million 9,925 10,248 8,323 8,156 7,484
Y / Y Net Income Change -8.72 % -22.97 % -14.31 % 57.48 % -41.68 %
Net Income in million 398 436 566 661 419
Annual Return On Assets 4.01 % 4.25 % 6.8 % 8.1 % 5.6 %




Comment on HSIC's ROA in the fiscal year ending 2024
In the fiscal year 2024 Henry Schein Inc 's ROA decreased compared to previous year to 4.01 %, due to deterioration of net income -8.72 % to $398.00 million, from $436.00 million a year ago, as HSIC's assets were $9,925.00 million.


More Return On Assets Ratios
HSIC's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
HSIC's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Roa for HSIC's Competitors
Roa for Henry Schein Inc 's Suppliers
Return On Assets for HSIC's Customers

You may also want to know
HSIC's Roi HSIC's Inventory Turnover Ratio HSIC's Growth Rates HSIC's Dividend Comparisons
HSIC's Profitability Ratios HSIC's Asset Turnover Ratio HSIC's Dividend Growth
HSIC's Roe HSIC's Valuation Ratios HSIC's Financial Strength Ratios HSIC's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 29 2025, within Healthcare Sector ROA
Ufp Technologies Inc   10.88 %
Gilead Sciences Inc   10.67 %
3m Company  10.67 %
Encompass Health Corporation  10.06 %
Utah Medical Products Inc  9.97 %
Royalty Pharma Plc  9.89 %
Cannapharmarx Inc   9.85 %
Lemaitre Vascular Inc   9.78 %
Gyre Therapeutics Inc   9.33 %
Sunlink Health Systems Inc   9.13 %
Entrada Therapeutics Inc   9.04 %
X4 Pharmaceuticals Inc  8.78 %
Neurocrine Biosciences Inc   8.59 %
Amphastar Pharmaceuticals Inc   8.58 %
Universal Health Services Inc   8.44 %
Concentra Group Holdings Parent Inc   8.42 %
Protagonist Therapeutics inc   8.31 %
Dexcom Inc   8.11 %
Tenet Healthcare Corp  8.05 %
Pacific Health Care Organization Inc  7.96 %
Castle Biosciences Inc   7.92 %
Progyny Inc   7.79 %
Aurinia Pharmaceuticals Inc   7.49 %
Biomarin Pharmaceutical Inc  7.47 %
Ardent Health Partners Inc   7.44 %
Viemed Healthcare Inc   7.27 %
National Healthcare Corp  7.24 %
Tg Therapeutics Inc   7.05 %
Mannkind Corporation  7.04 %
Davita Inc   6.83 %


Date modified: 2025-05-06T07:48:28+00:00


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com